Fig. 3.
Pan02 cell migration when treated with the plasma fraction of stored pRBCs with or without gefitinib (G) was significantly decreased in cells exposed to “outdate,” D.42 NLR blood (*p<0.001). Treatment with gefitinib did not affect Pan02 migration in cells exposed to “outdate” D.42 LR or any D.1 blood. HPF high-powered field, DMEM Dulbecco’s minimal essential medium